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Abstract
Background: Hwang-Heuk-San (HHS), a Korean traditional herbal formula comprising four medicinal herbs, has
been used to treat patients with inflammation syndromes and digestive tract cancer for hundreds of years; however, its
anti-inflammatory potential is poorly understood. The aim of the present study was to investigate the anti-inflammatory
effects of HHS using a lipopolysaccharide (LPS)-activated RAW 264.7 macrophage model.
Methods: The inhibitory effects of HHS on LPS-induced nitric oxide (NO), interleukin-1β (IL-1β) and tumor necrosis
factor-α (TNF-α) production were examined using Griess reagent and enzyme-linked immunosorbent assay (ELISA)
detection kits. The effects of HHS on the expression of inducible NO synthase (iNOS), IL-1β and TNF-α, their upstream
signal proteins, including nuclear factor κB (NF-κB), mitogen-activated protein kinases (MAPKs), and activator protein
(AP-1), were also investigated.
Results: A noncytotoxic concentration of HHS significantly reduced the production of NO, IL-1β and TNF-α in
LPS-stimulated RAW 264.7 cells, which was correlated with reduced expression of iNOS, IL-1β and TNF-α at the
mRNA and protein levels. HHS efficiently blocked the phosphorylation of MAPKs, especially that of extracellular
signal-regulated kinase (ERK) and c-Jun NH2-terminal kinase (JNK) but not that of the p38 MAPK. The reduced
production of inflammatory molecules by HHS was followed by decreased activity of NF-κB and AP-1.
Conclusions: These results suggest that HHS may offer therapeutic potential for treating inflammatory diseases
accompanied by macrophage activation.
Keywords: Hwang-Heuk-San, RAW 264.7 macrophage, anti-inflammation, MAPKs, NF-κB/AP-1
Background
There is increasing awareness that inflammation is a
natural defense system found in the human body and that
it plays a major role in the pathogenesis of many inflamma-
tory disorders [1, 2]. Although macrophages are important
in the host-defense mechanism, pathogen-induced overpro-
duction of inflammatory factors from macrophages and
cellular damage-derived inflammation-inducing molecules
have been implicated in inflammation-related diseases, such
as arthritis, inflammatory bowel diseases, and asthma [3].
Accumulating evidence indicates that specific stimuli,
such as the endotoxin lipopolysaccharide (LPS), a compo-
nent of the outer membrane of gram-negative bacteria,
give rise to the activation of macrophages and result in the
secretion of a number of different proinflammatory
mediators and cytokines, including nitric oxide (NO),
interleukin-1β (IL-1β) and tumor necrosis factor-α
(TNF-α) [3–5]. LPS can bind to toll-like receptor 4
(TLR4), which is expressed on macrophages. This
complex activates various cellular signaling events,
including mitogen-activated protein kinases (MAPKs),
and subsequently induces the activation of various
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transcription factors, such as nuclear factor (NF)-κB
and activator protein (AP-1) [6, 7].
MAPKs, extracellular signal regulated kinase (ERK), c-Jin
NH2-terminal kinase (JNK), and p38 MAPK are a group
of signaling molecules that also play an important role in
relaying inflammatory information from the extracellular
space to the cytoplasm and nucleus to modulate inflamma-
tory responses [7, 8]. Phosphorylation-induced activation
of MAPKs is known to be a critical component in the pro-
duction of proinflammatory molecules in activated macro-
phages. Previous studies have shown that TLR4-induced
activation of MAPKs resulted in the activation of the
nuclear translocation of NF-κB and AP-1 and, finally, the
initiation of proinflammatory responses [9, 10]. Under nor-
mal physiological conditions, NF-κB dimmers of p50 and
p65 subunits are present in the cytoplasm and attached to
the suppressor protein inhibitor of NF-κB (IκB). NF-κB
activation occurs via phosphorylation and subsequent acti-
vation of MAPKs, followed by degradation of IκB bound to
NF-κB, resulting in the translocation of NF-κB from the
cytoplasm to the nucleus to promote the expression of
various proinflammatory genes [6, 11]. AP-1 is an im-
portant regulator of gene expression involved in inflam-
mation activation, and it forms heterodimer complexes
with c-Jun and c-Fos. Various factors, including growth
factors, cytokines, and stress, induce AP-1 [7, 8]. AP-1
is activated by TLR agonists and cytokines, dependent on
the activation of MAPKs. Therefore, treatments aimed at
inhibiting MAPKs and NF-κB, as well as AP-1, may have
potential therapeutic advantages as anti-inflammatory
agents [12, 13].
For thousands of years, herbal medicines have been
used with apparent safety and efficacy for alleviating and
treating various diseases in many countries. Recently,
there has been increasing interest in the pharmacological
activity of traditional herbal formulas that are widely
used in traditional medicine in East Asia, including
Korea, China, and Japan, and numerous studies support
their potential clinical benefit for diseases that are diffi-
cult to treat [14, 15]. Typical traditional Korean medi-
cinal prescriptions derived from ancient Chinese herbal
medicines consist of more than four components that
are mixed to minimize side effects, maximize medical
effects, and improve the patient’s quality of life [16, 17].
Among them, Hwang-Heuk-San (HHS) is an aqueous
polyherbal formulation comprising four medicinal herbs
(Table 1). HHS has been used to treat patients with
inflammation syndromes and digestive tract cancer in
traditional Korean medicine. Despite its valuable clinical
effects on patients, little is known about the molecular
pharmacological basis of the effects of HHS. In this study,
as part of our ongoing screening program to evaluate the
anti-inflammatory potential of new compounds from
traditional medicinal resources, we investigated the impact
of HHS on the inflammatory response of LPS-challenged
RAW 264.7 macrophages, as well as the signaling path-
ways involved in these processes. Our data suggest that
HHS inhibits LPS-induced NO, IL-1β and TNF-α produc-
tion in RAW 264.7 cells, at least in part, through blockade
of the NF-κB, MAPK, and AP-1 signaling pathways.
Methods
Materials and reagents
Dulbecco’s modified Eagle's medium (DMEM) and fetal
bovine serum (FBS) were purchased from WelGENE Inc.
(Daegu, Republic of Korea). LPS (Escherichia coli Sero-
type 055:B5), 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-
tetrazolium bromide (MTT), and Griess reagent were
from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA).
Mouse IL-1β and TNF-α enzyme-linked immunosorbent
assay (ELISA) detection kits, and enhanced chemilumines-
cence (ECL) detection system were purchased from R&D
Systems (Minneapolis, MN, USA) and Amersham Co.
(Arlington Heights, IL, USA), respectively. Various pri-
mary and secondary antibodies for Western blot analysis
were purchased from Cell Signaling Technology, Inc.
(Boston, MA, USA) and Santa Cruz Biotechnology (Santa
Cruz, CA, USA). All other chemicals were purchased
from Sigma-Aldrich Chemical Co.
Preparation of the HHS
The four medicinal herbs forming HHS were obtained
from Dongeui Oriental Hospital, Dongeui University
College of Korean Medicine (Busan, Republic of Korea).
The origin of the medicinal herbs was confirmed taxonom-
ically by Professor Su Hyun Hong, Dongeui University
College of Korean Medicine (Busan, Republic of Korea).
Each of the four herbs in HHS was cut into small pieces
and then mixed together to obtain a total amount of 76 g
in the ratios shown in Table 1. The mixture was boiled
with distilled water (76 g/500 ml) for 3 h. The extract
solution was filtered using a 0.45-mM filter to remove
insoluble materials, and the blended supernatants were
lyophilized and then crushed into a thin powder (yield =
21 % w/w, dried extract/crude herb). The dried extract
was dissolved to a 100 mg/ml concentration with distilled
water before use, and the stock solution was then diluted
with medium to the desired concentration prior to use.





Rheum palmatum L. (Rhei Radix et Rhizoma) 36.0 (47.4)
Psoralea corylifolia L. (Psoraleae Fructus) 16.0 (21.0)
Pharbitis nil Chois. (Pharbitidis Semen) 16.0 (21.0)
Arctium lappa L. (Arctii Fructus) 8.0 (10.5)
Total amounts 76 (100)
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Cell culture and LPS stimulation
A murine macrophage cell line RAW 264.7 was obtained
from the American Type Culture Collection (Manassas,
VA, USA) and grown in DMEM containing 10 % FBS,
100 U/ml of penicillin, and 100 mg/ml of streptomycin
in an incubator at 37 °C, 5 % CO2, and 95 % humidity.
To stimulate the cells, the medium was exchanged with
fresh DMEM, and LPS (100 ng/ml) was added in the
presence or absence of HHS for the indicated periods.
Assessment of cell viability
The effects of HHS on cell viability were evaluated using
a colorimetric MTT assay. In brief, the RAW 264.7 cells
were seeded at a density of 1 × 104 cells/well in a 96
well-plate, incubated at 37 °C for 24 h, and treated with
various concentrations of HHS alone or with LPS
(100 ng/ml). After incubation for 24 h, the medium was
discarded, and MTT solution was added to each well
and incubated for another 3 h at 37 °C. The medium
was discarded, and dimethyl sulfoxide was added to dis-
solve the formazan dye. The optical density was the read
at 450 nm using an ELISA reader (Infinite M200, Tecan,
Männedorf, Switzerland).
Measurement of NO production
The accumulation of NO was assayed using Griess re-
agent. In brief, the cells were pretreated with different
concentrations of HHS for 1 h and stimulated with LPS
for 24 h. Then, 100 μl of the Griess reagent were mixed
with an equal volume of cell supernatant and incubated
at room temperature for 5 min. The optical density at
540 nm was measured, and the concentration of nitrite
was calculated according to the standard curve generated
from known concentrations of sodium nitrite [18].
IL-1β and TNF-α immunoassay
After treatment with HHS in the presence or absence of
LPS, the levels of IL-1β and TNF-α in the culture media
were quantified using ELISA kits according to the manu-
facturer’s instructions. The absorbance was read at a
wavelength of 450 nm using a microplate reader [19].
RNA isolation and reverse transcriptase polymerase chain
reaction (RTPCR)
Total RNA was isolated using TRIzol reagent (Invitrogen
Life Technologies, Carlsbad, CA, USA) according to the
manufacturer’s instructions and reverse transcribed using
MMLV reverse transcriptase (Promega, Madison, WI,
USA) to produce cDNAs. RT-generated cDNAs encoding
iNOS, IL-1β and TNF-α genes were amplified by PCR
using selective primers (Table 2), which were purchased
from Bioneer (Seoul, Republic of Korea). Thermal cycling
was carried out for 30 s at 95 °C, followed by 40 cycles of
5 s at 95 °C, and 30 s at 60 °C. Following amplification, the
PCR reactants were electrophoresed in 1 % agarose gels
and visualized by ethidium bromide (EtBr) staining. In a
parallel experiment, glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) was used as an internal control [20].
Western blot analysis
The cells were washed and scraped into cold phosphate-
buffered saline (PBS) and centrifuged at 500 × g at 4 °C.
The cell pellets were resuspended in lysis buffer (20 mM
sucrose, 1 mM ethylenediaminetetraacetic acid, 20 μM
Tris-HCl, pH 7.2, 1 mM dithiothreitol, 10 mM KCl,
1.5 mM MgCl2, and 5 μg/ml aprotinin). After cell debris
was discarded following centrifugation at 13,000 g for
15 min, the protein concentration was determined using a
Bio-Rad kit (Bio-Rad Laboratories, Hercules, CA, USA).
In a parallel experiment, nuclear and cytosolic proteins
were prepared using nuclear extraction reagents (Pierce
Biotechnology, Rockford, IL, USA) according to the
manufacturer’s protocol. Equal amounts of protein from
each sample were separated by sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis and transferred
onto nitrocellulose membranes (Schleicher & Schuell,
Keene, NH, USA). Nonspecific sites were blocked by the
incubating membranes for 1 h at room temperature in
5 % (w/v) nonfat milk powder in Tris-buffered saline con-
taining 0.05 % (v/v) Tween-20 (TBS-T). Thereafter, the
membranes were incubated overnight at 4 °C with the
corresponding primary antibodies and subsequently incu-
bated with the appropriate secondary antibodies conju-
gated to horseradish peroxidase. The specific proteins
were detected using an ECL detection system.
Immunofluorescent staining for NF-κB p65
RAW 264.7 cells were seeded on glass coverslips in 6-
well plates for 24 h, and the cells were treated with HHS
for 1 h and then stimulated with LPS for 30 min. Then,
the cells were fixed with 3.7 % paraformaldehyde in PBS
for 10 min at 4 °C. The cells were incubated with 0.4 %
Triton X-100 for 10 min and blocked with 5 % bovine
serum albumin for 1 h, followed by probing with rabbit
anti-p65 NF-κB antibody overnight at 4 °C. They were then
incubated with fluorescein isothiocyanate (FITC)-conju-
gated donkey anti-rabbit IgG (Jackson ImmunoResearch
Table 2 Primers of targeted genes
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Laboratories Inc., West Grove, PA, USA) for 2 h at room
temperature. After washing with PBS, nuclei were counter-
stained with 4,6-diamidino-2-phenyllindile (DAPI) solution
(1 mg/ml) for 15 min in the dark, and fluorescence was
visualized using a fluorescence microscope (Carl Zeiss,
Oberkochen, Germany) [21].
Electrophoretic mobility assay (EMSA)
DNA-protein binding assays were carried out with nuclear
extract. Briefly, the preparation of nuclear extracts was
conducted using NE-PER nuclear extraction reagents
(Pierce, Rockford, IL, USA). Synthetic complementary
NF-κB (5'-AGT TGA GGG GAC TTT CCC AGG C-3')
and AP-1 (5'-CGC TTG ATG ACT CAG CCG GAA-3')
binding oligonucleotides (Santa Cruz Biotechnology) were
30-biotinylated using a biotin 30-end DNA labeling kit
(Pierce) according to the manufacturer’s instructions and
annealed for 30 min at room temperature. The reaction
mixtures were electrophoretically separated on 4 %
polyacryl-amide gels in 0.5× Tris-borate buffer and
transferred to nylon membranes. The transferred DNAs
were cross-linked to the membranes at 120 mJ/cm2 and
detected using horseradish peroxidase-conjugated strepta-
vidin (LightShift™ chemiluminescent EMSA kit, Pierce)
according to the manufacturer’s instructions.
Statistical analysis
Data from at least three independent experiments were
expressed as the mean ± standard deviation (SD). Statistical
comparisons between different groups were performed
using a one-way ANOVA, followed by Student’s t-tests
after comparing each treated group to the negative control.
Values of p < 0.01 were considered statistically significant.
Results
HHS inhibited the release of NO and expression of iNOS
in LPS-stimulated RAW 264.7 cells
NO production is a widely used indicator of macrophage
activation among many inflammatory mediators. iNOS
expression generated in activated macrophages mediates
the synthesis of NO, which is then released into the cul-
ture medium [22, 23]. In the present study, RAW 264.7
cells were challenged with LPS in the presence or ab-
sence of HHS, and the levels of NO were measured by
Griess reagent. As presented in Fig. 1a, the pretreatment
with HHS concentration-dependently suppressed NO
secretion, with statistical significance. Next, we investi-
gated whether the inhibitory effect of HHS on NO pro-
duction was related to the modulation of iNOS enzyme
levels. Figure 1b demonstrates that HHS strongly sup-
pressed the protein expression of iNOS compared with
that of the LPS only-treated group. Furthermore, HHS
markedly repressed iNOS mRNA expression in the
LPS-stimulated RAW 264.7 cells (Fig. 1c), suggesting
that the HHS-mediated inhibition of NO production is
associated with transcriptional downregulation of the
iNOS gene.
HHS inhibited the release and expression of IL-1β and
TNF-α in LPS-stimulated RAW 264.7 cells
Proinflammatory cytokines, such as IL-1β and TNF-α,
produced in response to inflammatory stimuli can con-
tribute to inflammation [3, 24]. Thus, they are regarded
as targets for inhibiting the inflammatory process. To
confirm the effect of HHS on the production of proin-
flammatory cytokines, the IL-1β and TNF-α concentra-
tion in the culture medium was measured by ELISA.
Consistent with the NO results, HHS also inhibited IL-
1β and TNF-α production in a concentration-dependent
manner (Figs. 2a and 3b). To confirm whether the inhib-
ition of IL-1β and TNF-α production by HHS was due
to decreased IL-1β and TNF-α expression, we examined
the levels of IL-1β and TNF-α mRNA and protein after
Fig. 1 Inhibition of NO production and iNOS expression by HHS in
LPS-stimulated RAW 264.7 macrophages. The cells were pretreated
with various concentrations of HHS for 1 h and then incubated with
LPS (100 ng/ml) for 24 h. a The amount of NO production in the
medium was measured using the Griess reaction. Statistical significance
was determined by a one-way ANOVA (*, p < 0.05 vs. untreated
control; #, p < 0.05 vs. LPS-treated group). b Total cellular proteins
(30 μg) were resolved by SDS-polyacrylamide gel electrophoresis,
transferred to nitrocellulose membranes, and detected with anti-iNOS
antibody and an ECL detection system. c After LPS treatment for 6 h,
total RNA was prepared for RT-PCR analysis of iNOS gene expression.
The amplified PCR products were run in 1 % agarose gel and visualized
by EtBr staining. Actin and GAPDH were used as internal controls for
the Western blot and RT-PCR assays, respectively
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treating the LPS-stimulated RAW 264.7 cells with HHS.
As presented in Fig. 2b, c, 3b and c, HHS suppressed
both the protein and mRNA expression of IL-1β and
TNF-α in a concentration-dependent manner. These re-
sults showed that HHS was able to inhibit the expression
of IL-1β and TNF-α at the transcriptional level, which,
in turn, reduced the production of IL-1β and TNF-α in
the LPS-stimulated RAW 264.7 cells.
HHS inhibited the activation of the NF-κB pathway in
RAW 264.7 macrophages upon LPS stimulation
As NF-κB plays a pivotal role in the regulation of the
expression of inflammatory mediators and cytokines, it
is a good target for treating inflammatory diseases.
Moreover, many anti-inflammatory compounds exert
their effects by inhibiting the NF-κB signaling pathway
[6, 11]. Therefore, we investigated whether HHS sup-
pressed the degradation of IκB and the nuclear trans-
location of NF-κB by Western blotting analysis after
pretreating the cells with the indicated concentrations
of HHS for 1 h and stimulated with LPS for 30 min.
The treatment with LPS alone markedly increased the
nuclear levels of p65, a component of the heterodimer
of NF-κB, and HHS effectively blocked the LPS-
induced accumulation of NF-κB p65 in the nucleus in a
concentration-dependent manner (Fig. 4a). We next ex-
amined the ability of HHS to inhibit the degradation of
IκBα in the cytoplasm and found that HHS promoted
the cytosolic accumulation of IκBα. The immunofluor-
escence images also revealed that NF-κB p65 was nor-
mally sequestered in the cytoplasm, and nuclear
translocation of NF-κB p65 was not observed in the
cells after treatment with HHS alone in the absence of
LPS stimulation (Fig. 4b). LPS stimulation significantly
induced the nuclear localization of NF-κB p65 in RAW
264.7 cells, whereas pretreating the cells with HHS
abolished this effect. To confirm whether HHS affected
the activation of NF-κB, the DNA-binding activity of
NF-κB was investigated by an EMSA. The results re-
vealed significantly reduced DNA-binding activity of
Fig. 2 Inhibition of IL-1β production and its expression by HHS in
LPS-stimulated RAW 264.7 macrophages. The cells were pretreated
with various concentrations of HHS for 1 h and then incubated with
LPS (100 ng/ml) for 24 h. a The amounts of IL-1β were measured in
culture media using a commercial ELISA kit. Statistical significance was
determined by a one-way ANOVA (*, p < 0.05 vs. untreated control; #,
p < 0.05 vs. LPS-treated group). b Total cellular proteins (30 μg) were
resolved by SDS-polyacrylamide gel electrophoresis, transferred to
nitrocellulose membranes, and detected with anti-IL-1β antibody and
an ECL detection system. c After LPS treatment for 6 h, total RNA was
prepared for RT-PCR analysis of IL-1β gene expression. The amplified
PCR products were run in 1 % agarose gel and visualized by EtBr
staining. Actin and GAPDH were used as internal controls for the
Western blot and RT-PCR assays, respectively
Fig. 3 Inhibition of TNF-α production and its expression by HHS in
LPS-stimulated RAW 264.7 macrophages. The cells were pretreated
with various concentrations of HHS for 1 h and then incubated with
LPS (100 ng/ml) for 24 h. a The amounts of TNF-α were measured in
culture media using a commercial ELISA kit. Statistical significance was
determined by a one-way ANOVA (*, p < 0.05 vs. untreated control; #,
p < 0.05 vs. LPS-treated group). b Total cellular proteins (30 μg) were
resolved by SDS-polyacrylamide gel electrophoresis, transferred to
nitrocellulose membranes, and detected with anti-TNF-α antibody and
an ECL detection system. c After LPS treatment for 6 h, total RNA was
prepared for RT-PCR analysis of TNF-α gene expression. The amplified
PCR products were run in 1 % agarose gel and visualized by EtBr
staining. Actin and GAPDH were used as internal controls for the
Western blot and RT-PCR assays, respectively
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NF-κB in the nuclear extracts obtained from the LPS-
activated macrophages pretreated with HHS (Fig. 4c).
These results suggested that HHS effectively inhibited
LPS-induced NF-κB activation by blocking the nuclear
translocation of NF-κB and the degradation of IκBα.
HHS attenuated LPS-induced AP-1 activation in RAW
264.7 macrophages
Inflammatory mediators and cytokines were mediated
not only by NF-κB but also by another transcription
factor, AP-1, which is activated by JNK [6, 7]. Several
AP-1 family or CRE binding proteins have been shown
to translocate to the nucleus during LPS stimulation
[7, 12]. To evaluate the effect of HHS on the transcrip-
tional activity of AP-1, the DNA-binding activity of
AP-1 was measured by an EMSA. As depicted in
Fig. 5a, treatment with LPS for 60 min increased the
DNA-binding activity of AP-1 to its consensus DNA
sequence. However, pretreatment with HHS attenuated
this LPS-induced AP-1-DNA binding, suggesting that
HHS inhibited AP-1 activity. Following inflammatory
stimulation, the AP-1 heterodimers c-Jun and c-Fos
are translocated into the nucleus, leading to the transcrip-
tional activation of several inflammatory genes [7, 8]. We
confirmed the inhibitory pattern of AP-1 by measuring
the nuclear levels of c-Jun and c-Fos, in addition to their
phosphorylation levels. As shown in Fig. 5b, when the
cells were stimulated with LPS, the accumulation and
phosphorylation of c-Jun and c-Fos markedly increased.
However, upon HHS pretreatment, LPS-induced expres-
sion and phosphorylation of c-Jun and c-Fos was signifi-
cantly attenuated (Fig. 5b). These results indicated that
the anti-inflammatory effect of HHS on LPS-activated
RAW 264.7 cells might occur through NF-κB, as well as
AP-1, signaling pathways.
Effects of HHS on the cell viability of LPS-stimulated RAW
264.7 macrophages
The effects of HHS on the viability of the RAW 264.7
cells were finally determined after incubation with or
without LPS in the absence or presence of HHS. The
relative cell viability was calculated by the absorbance
of the untreated control group compared with the
absorbance of each sample-treated group. The concen-
trations (100 to 300 μg/ml) of HHS used in this study
did not show any cytotoxicity (Fig. 6), confirming that
the anti-inflammatory potential of HHS in the LPS-
stimulated RAW 264.7 cells was not due to any cyto-
toxic action of HHS.
Fig. 4 Attenuation of LPS-induced NF-κB activation by HHS in RAW 264.7 macrophages. a The cells were treated with the indicated concentrations of
HHS for 1 h before LPS treatment (100 ng/ml) for 30 min. Nuclear and cytosolic proteins were resolved on 10 % SDS-polyacrylamide gels, followed by
Western blotting using anti-NF-κB p65 and anti-IκBα antibodies. Lamin B and actin were used as internal controls for the nuclear and cytosolic fractions,
respectively. b Cells were pretreated with 300 μg/ml of HHS for 1 h prior to stimulation with LPS (100 ng/ml) for 30 min. Localization of NF-κB p65 was
visualized with a fluorescence microscope after immunofluorescence staining with anti-NF-κB p65 antibody and an FITC-labeled anti-rabbit IgG antibody
(green). Nuclei of the corresponding cells were visualized with DAPI (blue). c Following treatment with 300 μg/ml of HHS for 1 h, the cells were treated
with 100 ng/ml of LPS for 30 min. Nuclear extracts were prepared, and the DNA binding activity of NF-κB was analyzed by an EMSA
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HHS suppressed LPS-induced phosphorylation of ERK and
JNK in RAW 264.7 macrophages
MAPK signaling activated by phosphorylation plays an
important role in NF-κB activation, and the inhibition of
the MAPK pathway is sufficient to block the induction
of proinflammatory factors by LPS [13, 25]. Thus, we ex-
amined the inhibitory effect of HHS on the activation of
the MAPK pathway. To investigate whether HHS atten-
uated inflammatory responses through MAPK pathways,
we assessed the effect of HHS on the LPS-induced phos-
phorylation of several MAPKs, including ERK, JNK, and
p38 MAPK in RAW 264.7 cells. As shown in Fig. 7, ERK
and JNK phosphorylation increased after the treatment
with LPS for 30 min. However, pretreatment with HHS
significantly attenuated the phosphorylation levels of
these kinases compared with those of the LPS only-
treated group. On the other hand, when the RAW 264.7
cells were stimulated with HHS alone, the level of phos-
phorylated p38 MAPK significantly increased, as it did
with the LPS-only treatment. Moreover, HHS did not
appear to have any effect on the LPS-induced phosphor-
ylation of p38 MAPK. In addition, HHS did not affect
the total forms of the three MAPKs, either in the pres-
ence or absence of LPS. These results indicated that the
anti-inflammatory effect of HHS was possibly mediated
via the blockage of ERK and JNK phosphorylation but
that it was independent of the activation of p38 MAPK.
Discussion
In this study, we evaluated the anti-inflammatory ac-
tivities of HHS, a Korean traditional herbal formula, in
LPS-stimulated RAW 264.7 murine macrophages in an
attempt to source an anti-inflammatory agent from
traditional medicinal resources with more effectiveness
than current agents. Our results indicated that i) HHS
significantly inhibited LPS-induced production of NO
through the downregulation of iNOS expression; ii)
HHS markedly suppressed LPS-induced release and
expression of IL-1β and TNF-α; iii) HHS inhibited
LPS-induced phosphorylation of ERK and JNK, but not
p38 MAPK; iv) HHS attenuated the activation of NF-κB
by blocking the nuclear translocation NF-κB and degrad-
ation of IkB; and v) HHS markedly inhibited LSP-induced
activation AP-1 by suppressing the phosphorylation of
c-Jun and c-Fos. The results presented in this study
demonstrate that the underlying anti-inflammatory
mechanisms of HHS are due, at least in part, to inhibition
of LPS-induced activation of NF-κB, MAPK, and AP-1
signaling pathways.
The overproduction of proinflammatory mediators
and cytokines by activated macrophages causes various
inflammatory diseases [3, 26]. Therefore, identifying new
agents capable of lowering the production of proinflam-
matory agents is regarded as an essential requirement
for the alleviation of a number of inflammation-related
disorders attributed to macrophage activation [12, 27].
In the present study, the production of NO was markedly
elevated in response to LPS. However, the application of
HHS inhibited the production of NO by LPS in a
concentration-dependent manner (Fig. 1a). The results
from the RT-PCR and Western blot analysis showed that
pretreatment with HHS concentration-dependently re-
duced iNOS mRNA levels, with correlated reductions in
the corresponding protein level (Figs. 1b and c). In
addition, HHS was highly effective at inhibiting IL-1β and
TNF-α production, which was associated with a reduction
of mRNA and protein expression of IL-1β and TNF-α in
Fig. 5 Suppression of LPS-induced AP-1 activation by HHS in RAW
264.7 macrophages. a The cells were treated with 300 μg/ml of HHS
for 1 h before LPS treatment (100 ng/ml) for 30 min. Nuclear proteins
were resolved on 10 % SDS-polyacrylamide gels, followed by Western
blotting using the indicated antibodies. Lamin B was used as an internal
control for the nuclear fractions. b In a parallel experiment, nuclear
extracts were prepared, and the DNA binding activity of AP-1 was
analyzed by an EMSA
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the LPS-treated RAW 264.7 cells (Figs. 2 and 3). The
present data indicated that HHS reduced mRNA levels of
iNOS, IL-1β and TNF-α, which led to decreased protein
levels of iNOS, IL-1β and TNF-α, and consequently re-
duced the quantities of NO, IL-1β and TNF-α that were
produced by these enzymes.
The accumulated data demonstrates that specific tran-
scription factors are mainly responsible for the transcrip-
tional regulation of a variety of proinflammatory mediators
and cytokines from activated macrophages [7, 10]. Among
these, the NF-κB transcription factor family is a critical me-
diator of inflammatory processes. Thus, the inactivation of
NF-κB in the immune system is a major therapeutic target
for the downregulation of inflammatory responses. Along
with NF-kB activation, AP-1 is able to regulate the expres-
sion of a large number of proinflammatory genes, which
attract or activate immune cells [8, 11]. NF-κB and AP-1 is
composed mainly of two proteins: p65 and p50 or c-Jun
and c-Fos, respectively. In unstimulated cells, they exist in
the cytosol in a quiescent form. Upon stimulation with
LPS, they are activated and translocate to the nucleus
where they activate their target genes by binding to their
consensus sequences in their promoter regions. In addition
to the NF-κB and AP-1 signaling pathways, MAPKs are a
major group of signaling molecules that appear to play key
roles in inflammatory processes because the phosphoryl-
ation of MAPK can stimulate the activation of NF-κB and
AP-1 [27, 28]. Therefore, the MAPK signaling cascade is
also an attractive therapeutic target for the development of
treatments for inflammatory disorders.
In this study, Western blotting revealed that HHS was
able to inhibit the LPS-evoked degradation of IkB and
the nuclear translocation of NF-κB p65 (Fig. 4). Based
on these results, we tested whether HHS inhibited NF-
κB activity in RAW 264.7 macrophages by using an
EMSA and found that HHS inhibited LPS-induced
DNA-binding of NF-κB. To investigate whether the in-
hibition of NF-κB activation by HHS was associated with
the MAPK pathway, the LPS-induced phosphorylation
of various MAPKs family proteins, particularly ERK,
JNK, and p38 MAPK, was assessed. The immunoblotting
results revealed that HHS strikingly induced p38 MAPK
phosphorylation, but it had no effect on the activity of
ERK and JNK. In addition, the HHS pretreatment
abolished the LPS-induced phosphorylation of ERK
and JNK (Fig. 6). However, HHS failed to inhibit LPS-
induced p38 MAPK phosphorylation, indicating that
the anti-inflammatory responses by HHS may be inde-
pendent on the p38 MAPK signaling pathway. In sub-
sequent studies, the results from Western blotting of
Fig. 6 Effects of HHS and LPS on the cell viability of RAW 264.7 macrophages. The cells were treated with the indicated concentrations of HHS
alone or pretreated with HHS for 1 h before 100 ng/ml of LPS treatment. After 24 h, the cell viability was assessed using an MTT reduction assay.
Data are expressed as the mean ± SD of three independent experiments
Fig. 7 Effect of HHS on LPS-induced phosphorylation of MAPKs in
RAW 264.7 macrophages. The cells were pretreated with various
concentrations of HHS for 1 h prior to exposure to LPS (100 ng/ml)
for 30 min, and total proteins were isolated. The proteins were
subjected to SDS-polyacrylamide gels, followed by Western blot
analysis using the indicated antibodies and an ECL detection system
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nuclear extracts indicated that HHS inhibited the ex-
pression and phosphorylation of c-Jun and c-Fos in
LPS-challenged RAW 264.7 cells. Furthermore, the
EMSA results demonstrated that the DNA-binding
activity of AP-1 was significantly reduced in nuclear
extracts obtained from LPS-activated RAW 264.7 cells
that had been pretreated with HHS (Fig. 5). These re-
sults suggested that HHS blocked the binding of NF-
κB and AP-1 to specific sequences of DNA, thereby
preventing the formation of DNA/NF-κB and DNA/
AP-1 complexes. In addition, changes in the phos-
phorylation of ERK and JNK might mediate HHS-
induced inhibition of NF-κB and AP-1 transcriptional
activities. In particular, deficiencies in the phosphoryl-
ation of these kinases could lead to decreases in the
expression levels of inflammation-related genes.
Conclusions
In conclusion, our findings showed that HHS effectively
inhibited the LPS-induced production of proinflammatory
factors, such as NO, IL-1β and TNF-α, in RAW 264.7
macrophages without causing cytotoxicity. A possible
mechanism for this effect involves the ability of HHS to
activate a signaling cascade, which results in the repres-
sion of NF-κB, ERK, and JNK and the activation of AP-1
in LPS-challenged macrophages. Although further investi-
gation is needed to clarify the precise mechanisms by
which HHS inhibits NF-κB and AP-1 activation and to
identify the biologically active compounds of HHS
responsible for the observed effects, HHS may be con-
sidered a potential therapeutic agent for the treatment
of inflammation-related disease.
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